Predicting surgery difficulty for mid-lower rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether a computer model can help doctors predict how difficult the surgery will be, so they can choose the best surgical approach for removing middle to lower rectal cancer. It aims to make the operation safer and more effective for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are diagnosed with a type of rectal cancer called adenocarcinoma and have been advised to have surgery to remove it.
- Your tumor is in the middle or lower part of the rectum, roughly 1 to 7 centimeters from the anal opening.
- Your cancer is at an early or intermediate stage (not spread to distant organs like liver or lungs).
- You are well enough, in terms of heart, lungs, liver, and kidneys, to have laparoscopic (minimally invasive) surgery.
- You do not need to remove lymph nodes on the sides of the pelvis, and you do not have a history of severe mental illness or immune disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to help doctors make treatment decisions for rectal cancer. It looks at MRI reports and other medical information to suggest the best next steps, like surgery, radiation, or chemotherapy.
This study tests an AI system that helps identify cancer or polyp findings during rectal surgery or assessment, using real-time information. It may help surgeons classify tissue more accurately while you are already getting treatment.
This trial compares two types of robotic surgery for rectal cancer to see if they are equally safe and effective. It helps patients understand which approach might be better for their recovery and outcomes.
This trial looks at whether removing the rectal tumor locally (through the anus) can work as well as a more extensive operation after scans show no remaining cancer. It may help some people avoid bigger surgery if the cancer truly appears gone after treatment.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This trial compares a new surgery method that uses multiple technologies to remove rectal cancer more precisely versus the standard surgery. It is for people with middle or lower rectal cancer that hasn't spread, and it may help improve outcomes after surgery.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.